Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future.

Africa antimicrobial resistance antimicrobial stewardship programs antimicrobials national action plans quality indicators strategies surgical site infections utilization patterns

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
15 Dec 2022
Historique:
received: 17 11 2022
revised: 05 12 2022
accepted: 09 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

There are serious concerns with rising antimicrobial resistance (AMR) across countries increasing morbidity, mortality and costs. These concerns have resulted in a plethora of initiatives globally and nationally including national action plans (NAPs) to reduce AMR. Africa is no exception, especially with the highest rates of AMR globally. Key activities in NAPs include gaining a greater understanding of current antimicrobial utilization patterns through point prevalence surveys (PPS) and subsequently instigating antimicrobial stewardship programs (ASPs). Consequently, there is a need to comprehensively document current utilization patterns among hospitals across Africa coupled with ASP studies. In total, 33 PPS studies ranging from single up to 18 hospitals were documented from a narrative review with typically over 50% of in-patients prescribed antimicrobials, up to 97.6% in Nigeria. The penicillins, ceftriaxone and metronidazole, were the most prescribed antibiotics. Appreciable extended prescribing of antibiotics up to 6 days or more post-operatively was seen across Africa to prevent surgical site infections. At least 19 ASPs have been instigated across Africa in recent years to improve future prescribing utilizing a range of prescribing indicators. The various findings resulted in a range of suggested activities that key stakeholders, including governments and healthcare professionals, should undertake in the short, medium and long term to improve future antimicrobial prescribing and reduce AMR across Africa.

Identifiants

pubmed: 36551481
pii: antibiotics11121824
doi: 10.3390/antibiotics11121824
pmc: PMC9774141
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no relevant conflict of interest.

Références

J Family Med Prim Care. 2020 Jan 28;9(1):162-167
pubmed: 32110584
Antibiotics (Basel). 2020 Aug 29;9(9):
pubmed: 32872419
Expert Rev Anti Infect Ther. 2022 Oct;20(10):1365-1379
pubmed: 35912881
Expert Rev Clin Pharmacol. 2018 Dec;11(12):1255-1262
pubmed: 30451035
BMC Public Health. 2019 Jun 21;19(1):797
pubmed: 31226974
Int J Clin Pract. 2022 Oct 13;2022:3639943
pubmed: 36311485
BMC Res Notes. 2018 Jul 31;11(1):538
pubmed: 30064487
Euro Surveill. 2021 May;26(21):
pubmed: 34047271
PLoS One. 2020 Feb 10;15(2):e0228555
pubmed: 32040513
S Afr Med J. 2018 Jun 26;108(7):546-550
pubmed: 30004339
Life (Basel). 2021 Jun 07;11(6):
pubmed: 34200116
Vet Ital. 2021 May 11;57(1):5-12
pubmed: 34313093
J Infect. 2019 Jan;78(1):8-18
pubmed: 29981773
Front Pharmacol. 2014 Jun 17;5:106
pubmed: 24987370
Basic Clin Pharmacol Toxicol. 2015 Feb;116(2):146-57
pubmed: 25052464
J Glob Antimicrob Resist. 2022 Jun;29:542-550
pubmed: 34915203
Antibiotics (Basel). 2020 Jul 23;9(8):
pubmed: 32717942
J Pharm Policy Pract. 2022 Nov 17;15(1):84
pubmed: 36397142
JAC Antimicrob Resist. 2021 Jun 14;3(2):dlab080
pubmed: 34223139
J Hosp Infect. 2020 Jun;105(2):295-305
pubmed: 31931043
Nature. 2019 Jun;570(7760):189-193
pubmed: 31092927
J Patient Saf. 2022 Mar 1;18(2):e477-e479
pubmed: 33881808
Healthcare (Basel). 2022 Sep 06;10(9):
pubmed: 36141318
Int J Antimicrob Agents. 2020 Dec;56(6):106189
pubmed: 33045348
Expert Rev Anti Infect Ther. 2017 Oct;15(10):963-972
pubmed: 28922959
BMC Health Serv Res. 2020 Mar 19;20(1):234
pubmed: 32192481
Expert Opin Drug Saf. 2022 Aug;21(8):1089-1111
pubmed: 35876080
Expert Rev Anti Infect Ther. 2021 Oct;19(10):1353-1366
pubmed: 33724147
J Hosp Infect. 2020 Mar;104(3):321-327
pubmed: 31931045
PLoS One. 2019 Jan 16;14(1):e0209847
pubmed: 30650099
Antimicrob Resist Infect Control. 2020 Sep 7;9(1):149
pubmed: 32894182
Vaccines (Basel). 2022 Nov 15;10(11):
pubmed: 36423029
Front Public Health. 2020 Apr 09;8:109
pubmed: 32328474
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
Antibiotics (Basel). 2022 Aug 25;11(9):
pubmed: 36139929
J Infect Public Health. 2019 Nov - Dec;12(6):854-860
pubmed: 31196776
Antimicrob Resist Infect Control. 2020 May 11;9(1):63
pubmed: 32393348
PLoS One. 2021 Nov 2;16(11):e0259317
pubmed: 34727126
Pan Afr Med J. 2018 Apr 23;29:219
pubmed: 30100973
Antibiotics (Basel). 2022 Jun 09;11(6):
pubmed: 35740195
Future Sci OA. 2021 Jun 10;7(8):FSO736
pubmed: 34290883
PLoS One. 2017 Dec 21;12(12):e0189621
pubmed: 29267306
Hosp Pract (1995). 2019 Feb;47(1):53-58
pubmed: 29757036
Am J Trop Med Hyg. 2021 Oct 11;105(6):1510-1515
pubmed: 34634773
Qual Saf Health Care. 2002 Dec;11(4):358-64
pubmed: 12468698
Clin Infect Dis. 2015 Jan 15;60(2):281-91
pubmed: 25266285
JAC Antimicrob Resist. 2019 Nov 12;1(3):dlz072
pubmed: 34222945
JAC Antimicrob Resist. 2022 Oct 10;4(5):dlac102
pubmed: 36226227
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Int J Infect Dis. 2020 Oct;99:10-18
pubmed: 32781162
Pan Afr Med J. 2020 Jul 20;35(Suppl 2):119
pubmed: 33282074
Lancet Infect Dis. 2021 Jan;21(1):107-115
pubmed: 32717205
J Public Health Afr. 2022 Jan 13;12(2):2009
pubmed: 35126891
Curr Med Res Opin. 2020 Feb;36(2):301-327
pubmed: 31794332
Clin Microbiol Infect. 2022 Sep;28(9):1193-1202
pubmed: 35339675
Afr J Lab Med. 2022 Aug 31;11(1):1594
pubmed: 36091353
J Am Med Inform Assoc. 2015 Jan;22(1):236-42
pubmed: 25125688
PLoS One. 2022 Aug 1;17(8):e0272375
pubmed: 35913964
Lancet Infect Dis. 2016 Sep;16(9):1017-1025
pubmed: 27312577
Nat Microbiol. 2019 Sep;4(9):1432-1442
pubmed: 31439928
Int J Gen Med. 2021 Feb 18;14:515-530
pubmed: 33633461
PLoS One. 2022 Jan 21;17(1):e0260733
pubmed: 35061702
Hosp Pract (1995). 2018 Aug;46(3):97-102
pubmed: 29521136
Expert Rev Anti Infect Ther. 2017 Jul;15(7):713-721
pubmed: 28425828
Antibiotics (Basel). 2020 Nov 07;9(11):
pubmed: 33171743
Hosp Pract (1995). 2020 Mar 14;48(2):51-67
pubmed: 32196395
PLoS One. 2021 May 7;16(5):e0251301
pubmed: 33961678
BMJ. 2020 May 18;369:m1983
pubmed: 32423901
Int J Antimicrob Agents. 2021 Oct;58(4):106411
pubmed: 34371112
Basic Clin Pharmacol Toxicol. 2011 Apr;108(4):224-33
pubmed: 21414143
Antimicrob Resist Infect Control. 2019 Feb 12;8:35
pubmed: 30805182
Lancet Infect Dis. 2019 Dec;19(12):1278-1280
pubmed: 31782385
Lancet Infect Dis. 2018 Jan;18(1):18-20
pubmed: 29303731
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:73-8
pubmed: 23640191
Antibiotics (Basel). 2022 Mar 12;11(3):
pubmed: 35326841
JAC Antimicrob Resist. 2021 Jul 12;3(3):dlab087
pubmed: 34263166
Int J Qual Health Care. 2019 Jun 1;31(5):338-345
pubmed: 30169688
Expert Opin Pharmacother. 2019 Dec;20(18):2237-2255
pubmed: 31762343
Soc Sci Med. 2000 Dec;51(11):1611-25
pubmed: 11072882
Antibiotics (Basel). 2021 Aug 23;10(8):
pubmed: 34439074
Br J Surg. 2019 Jan;106(2):e121-e128
pubmed: 30620071
Antibiotics (Basel). 2020 Jun 09;9(6):
pubmed: 32526969
Clin Microbiol Infect. 2016 Oct;22(10):888.e1-888.e9
pubmed: 27432770
Front Med (Lausanne). 2022 May 19;9:820544
pubmed: 35665358
Trop Med Infect Dis. 2021 Sep 13;6(3):
pubmed: 34564550
BMC Infect Dis. 2017 Sep 11;17(1):616
pubmed: 28893183
Expert Rev Pharmacoecon Outcomes Res. 2020 Feb;20(1):1-26
pubmed: 32237953
PLoS One. 2019 Jan 29;14(1):e0211157
pubmed: 30695078
Antimicrob Resist Infect Control. 2020 May 19;9(1):69
pubmed: 32430026
PLoS One. 2022 Jun 16;17(6):e0270048
pubmed: 35709220
Infect Dis Rep. 2017 Mar 30;9(1):6821
pubmed: 28458795
Antibiotics (Basel). 2022 Sep 07;11(9):
pubmed: 36139990
Lancet Glob Health. 2019 Jul;7(7):e861-e871
pubmed: 31200888
BMJ Glob Health. 2019 Nov 10;4(6):e002104
pubmed: 31799007
S Afr Med J. 2017 Jan 30;107(2):115-118
pubmed: 28220735
Int J Qual Health Care. 2021 Aug 13;33(3):
pubmed: 34390247
Front Pharmacol. 2021 Jan 14;11:588106
pubmed: 33628173
PLoS One. 2013 Nov 11;8(11):e78942
pubmed: 24244390
Infect Prev Pract. 2020 Jul 08;2(3):100075
pubmed: 34368716
Expert Rev Anti Infect Ther. 2015 Feb;13(2):279-89
pubmed: 25495147
Lancet Infect Dis. 2018 Feb;18(2):e33-e44
pubmed: 29033034
BMC Pediatr. 2018 Dec 20;18(1):391
pubmed: 30572851
PLoS One. 2018 Sep 13;13(9):e0203523
pubmed: 30212477
Global Health. 2020 Nov 11;16(1):109
pubmed: 33176810
Expert Rev Anti Infect Ther. 2016 Dec;14(12):1215-1223
pubmed: 27548801
Clin Infect Dis. 2020 Dec 3;71(9):e478-e486
pubmed: 32060523
Front Med (Lausanne). 2022 Apr 25;9:898743
pubmed: 35547217
S Afr J Infect Dis. 2021 Nov 24;36(1):307
pubmed: 34917678
S Afr Med J. 2017 Apr 25;107(5):405-410
pubmed: 28492121
Front Cell Infect Microbiol. 2021 Nov 25;11:771510
pubmed: 34900756
J Antimicrob Chemother. 2017 Apr 1;72(4):1227-1234
pubmed: 27999061
J Pharm Policy Pract. 2020 Apr 22;13:7
pubmed: 32337049
BMC Vet Res. 2021 Jul 2;17(1):234
pubmed: 34215271
J Res Pharm Pract. 2019 Oct 16;8(3):149-154
pubmed: 31728346
BMJ Open. 2017 May 2;7(4):e014345
pubmed: 28465306
Hosp Pract (1995). 2018 Aug;46(3):128-136
pubmed: 29652559
PLoS Med. 2020 Jun 16;17(6):e1003139
pubmed: 32544153
Expert Rev Anti Infect Ther. 2022 Feb;20(2):297-306
pubmed: 34128756
Cureus. 2022 Jul 11;14(7):e26731
pubmed: 35967145
Front Public Health. 2020 Aug 27;8:454
pubmed: 32974264
BMC Res Notes. 2018 Dec 18;11(1):904
pubmed: 30563558
Antibiotics (Basel). 2022 Feb 04;11(2):
pubmed: 35203802
JNMA J Nepal Med Assoc. 2022 Feb 15;60(246):225-228
pubmed: 35210634
JAC Antimicrob Resist. 2020 Oct 05;2(3):dlaa070
pubmed: 34223026
Hum Vaccin Immunother. 2022 Dec 31;18(1):2027160
pubmed: 35113777
J Infect Dev Ctries. 2022 Nov 29;16(11):1739-1747
pubmed: 36449646
Biol Proced Online. 2022 Nov 23;24(1):19
pubmed: 36424530
PLoS One. 2019 Mar 7;14(3):e0213395
pubmed: 30845240
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Epidemiol Infect. 2020 Jul 01;148:e147
pubmed: 32605670
Implement Sci. 2019 Mar 4;14(1):20
pubmed: 30832678
Int J Antimicrob Agents. 2021 Apr;57(4):106324
pubmed: 33746045
JAC Antimicrob Resist. 2022 Jun 24;4(3):dlac069
pubmed: 35769809
S Afr Med J. 2018 Mar 28;108(4):304-310
pubmed: 29629681
Int J Clin Pharm. 2018 Oct;40(5):1037-1043
pubmed: 30054786
Int J Clin Pharm. 2020 Aug;42(4):1227-1236
pubmed: 32458227
J Antimicrob Chemother. 2018 Jun 1;73(suppl_6):vi40-vi49
pubmed: 29878218
Vaccines (Basel). 2022 Sep 17;10(9):
pubmed: 36146631
Hosp Pract (1995). 2022 Aug;50(3):214-221
pubmed: 35450508
J Glob Antimicrob Resist. 2019 Jun;17:132-136
pubmed: 30557686
J Infect Public Health. 2021 May;14(5):555-560
pubmed: 33848884
Nat Rev Microbiol. 2019 Jan;17(1):3
pubmed: 30467331
J Antimicrob Chemother. 2021 May 12;76(6):1614-1624
pubmed: 33822971
Front Public Health. 2022 Oct 18;10:946077
pubmed: 36330124
Expert Rev Anti Infect Ther. 2016 Sep;14(9):863-72
pubmed: 27351748
Lancet. 2016 Jan 9;387(10014):168-75
pubmed: 26603918
Expert Rev Anti Infect Ther. 2020 Sep;18(9):897-910
pubmed: 32394754
JAC Antimicrob Resist. 2021 Nov 17;3(4):dlab169
pubmed: 34806008
Vaccines (Basel). 2022 Apr 15;10(4):
pubmed: 35455375
EClinicalMedicine. 2021 Jan 29;32:100727
pubmed: 33554094
J Antimicrob Chemother. 2020 Jan 1;75(1):14-29
pubmed: 31834401
Int J Antimicrob Agents. 2018 Dec;52(6):771-782
pubmed: 30312654
JAMA Surg. 2019 Jul 1;154(7):590-598
pubmed: 31017647
Lancet Infect Dis. 2019 Jan;19(1):67-75
pubmed: 30522834
Trop Med Health. 2021 Jun 23;49(1):51
pubmed: 34162445
Microb Drug Resist. 2021 Dec;27(12):1705-1725
pubmed: 34077290
Turk J Pharm Sci. 2021 Jun 18;18(3):282-288
pubmed: 34157817
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Antibiotics (Basel). 2021 Dec 14;10(12):
pubmed: 34943740
BMC Infect Dis. 2014 Jan 09;14:13
pubmed: 24405683
BMC Fam Pract. 2011 Aug 10;12:85
pubmed: 21831317
One Health Outlook. 2021 Oct 19;3(1):18
pubmed: 34663477
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Surg Infect (Larchmt). 2020 Aug;21(6):540-546
pubmed: 32196425
Antibiotics (Basel). 2020 Aug 09;9(8):
pubmed: 32784880
Animals (Basel). 2020 Jul 24;10(8):
pubmed: 32722312
JAC Antimicrob Resist. 2020 Feb 18;2(1):dlaa001
pubmed: 34222959
Int J Clin Pharm. 2022 Apr;44(2):301-319
pubmed: 34843035
Hosp Pract (1995). 2019 Apr;47(2):88-95
pubmed: 30963821
Glob Health Action. 2021 Jan 1;14(1):1868055
pubmed: 33475046
Cell. 2020 Oct 15;183(2):296-300
pubmed: 33064983
PLoS One. 2017 Aug 24;12(8):e0183062
pubmed: 28837665
Hosp Pract (1995). 2022 Oct;50(4):306-317
pubmed: 35980901
Antibiotics (Basel). 2021 Sep 17;10(9):
pubmed: 34572704
Antimicrob Resist Infect Control. 2021 Jan 14;10(1):13
pubmed: 33446266
BMJ Glob Health. 2019 Apr 11;4(2):e001315
pubmed: 31139449
Germs. 2021 Dec 29;11(4):523-535
pubmed: 35096669
Am J Trop Med Hyg. 2020 Feb;102(2):370-376
pubmed: 31802729
J Glob Antimicrob Resist. 2020 Sep;22:317-324
pubmed: 32247077
Lancet Glob Health. 2021 May;9(5):e610-e619
pubmed: 33713630
BMJ Open. 2022 Feb 11;12(2):e054541
pubmed: 35149567
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
Science. 2019 Sep 20;365(6459):
pubmed: 31604207
Front Pharmacol. 2020 Mar 20;11:108
pubmed: 32265688
Antibiotics (Basel). 2022 Apr 18;11(4):
pubmed: 35453286
J Hosp Infect. 2022 Nov;129:124-143
pubmed: 35970382
Ann Afr Med. 2018 Jan-Mar;17(1):26-32
pubmed: 29363633
Expert Rev Anti Infect Ther. 2022 Feb;20(2):147-160
pubmed: 34225545
Front Pharmacol. 2020 Sep 11;11:1205
pubmed: 33071775
Expert Rev Clin Pharmacol. 2019 Feb;12(2):159-168
pubmed: 30407089
Hosp Pract (1995). 2021 Aug;49(3):184-193
pubmed: 33566710
Front Pharmacol. 2020 Mar 03;11:144
pubmed: 32194401
BMC Infect Dis. 2020 Jan 30;20(1):86
pubmed: 32000722
BMJ Open. 2020 Dec 15;10(12):e042819
pubmed: 33323448
Infect Prev Pract. 2020 Jul 28;2(4):100078
pubmed: 34368721
Antimicrob Resist Infect Control. 2018 Jan 26;7:15
pubmed: 29423190
J Res Pharm Pract. 2021 May 13;10(1):17-22
pubmed: 34295848
Expert Rev Anti Infect Ther. 2020 Jan;18(1):87-97
pubmed: 31834825
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
J Chemother. 2021 Feb;33(1):21-31
pubmed: 32693710
West Afr J Med. 2020 Jul-Aug;37(3):216-220
pubmed: 32476113
J Antimicrob Chemother. 2016 Jun;71(6):1697-706
pubmed: 26945712
J Glob Antimicrob Resist. 2019 Jun;17:291-295
pubmed: 30668994
Patient Prefer Adherence. 2021 Feb 25;15:467-473
pubmed: 33658770
Lancet Infect Dis. 2018 May;18(5):507-515
pubmed: 29519766
Front Public Health. 2020 Mar 24;8:90
pubmed: 32266200
JAC Antimicrob Resist. 2022 Feb 07;4(1):dlab196
pubmed: 35146427
J Chemother. 2019 Nov - Dec;31(7-8):378-387
pubmed: 31145043
Infect Dis Ther. 2015 Sep;4(Suppl 1):5-14
pubmed: 26362291
JAC Antimicrob Resist. 2021 Feb 08;3(1):dlab008
pubmed: 34223086
Pharmacy (Basel). 2020 Jun 24;8(2):
pubmed: 32599699
Front Public Health. 2020 Apr 28;8:140
pubmed: 32411647
Healthcare (Basel). 2021 Dec 13;9(12):
pubmed: 34946448
Antibiotics (Basel). 2022 Oct 17;11(10):
pubmed: 36290081
Antibiotics (Basel). 2019 Dec 20;9(1):
pubmed: 31861923
Appl Health Econ Health Policy. 2009;7(3):137-47
pubmed: 19799468
Pan Afr Med J. 2020 Jan 15;35:12
pubmed: 32341733
Open Forum Infect Dis. 2020 Dec 21;8(2):ofaa601
pubmed: 33553470
Lancet Infect Dis. 2018 Sep;18(9):e288-e294
pubmed: 29673734
Antibiotics (Basel). 2021 Feb 18;10(2):
pubmed: 33670731
Expert Rev Anti Infect Ther. 2019 Jul;17(7):535-546
pubmed: 31257952
Lancet Infect Dis. 2021 Oct;21(10):1429-1440
pubmed: 34332706
Infect Drug Resist. 2019 Dec 20;12:3903-3910
pubmed: 31908502
J Antimicrob Chemother. 2018 Oct 1;73(10):2613-2624
pubmed: 30020464
Front Pharmacol. 2020 Aug 18;11:1267
pubmed: 32973508
Antibiotics (Basel). 2022 Nov 15;11(11):
pubmed: 36421270
PLoS One. 2018 Oct 16;13(10):e0205166
pubmed: 30325963
Clin Microbiol Infect. 2017 Nov;23(11):812-818
pubmed: 28712667

Auteurs

Zikria Saleem (Z)

Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.

Brian Godman (B)

Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates.
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Molotlegi Street, Garankuwa, Pretoria 0208, South Africa.

Aislinn Cook (A)

Centre for Neonatal and Paediatric Infection, St. George's University of London, London SW17 0RE, UK.
Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford OX1 2JD, UK.

Muhammad Arslan Khan (MA)

The Indus Hospital, Bedian Road, Lahore 54000, Pakistan.

Stephen M Campbell (SM)

Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Molotlegi Street, Garankuwa, Pretoria 0208, South Africa.
Centre for Epidemiology and Public Health, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.
NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.

Ronald Andrew Seaton (RA)

Queen Elizabeth University Hospital, Govan Road, Glasgow G51 4TF, UK.
Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Delta House, 50 West Nile Street, Glasgow G1 2NP, UK.

Linda Siachalinga (L)

College of Pharmacy, Yeungnam University, Daehak-Ro, Gyeongsan, Gyeongbuk 38541, Republic of Korea.

Abdul Haseeb (A)

Department of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.

Afreenish Amir (A)

Department of Microbiology, Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi 46000, Pakistan.

Amanj Kurdi (A)

Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Molotlegi Street, Garankuwa, Pretoria 0208, South Africa.
Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil 44001, Iraq.
Center of Research and Strategic Studies, Lebanese French University, Erbil 44001, Iraq.

Julius C Mwita (JC)

Department of Internal Medicine, Faculty of Medicine, University of Botswana, Private Bag 0713 UB, Gaborone 00704, Botswana.

Israel Abebrese Sefah (IA)

Pharmacy Practice Department, School of Pharmacy, University of Health and Allied Sciences, Volta Region, Hohoe PMB 31, Ghana.

Sylvia A Opanga (SA)

Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi P.O. Box 19676-00202, Kenya.

Joseph O Fadare (JO)

Department of Pharmacology and Therapeutics, Ekiti State University, Ado Ekiti 362103, Nigeria.
Department of Medicine, Ekiti State University Teaching Hospital, Ado Ekiti 360211, Nigeria.

Olayinka O Ogunleye (OO)

Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos 100271, Nigeria.
Department of Medicine, Lagos State University Teaching Hospital, Ikeja 100271, Nigeria.

Johanna C Meyer (JC)

Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Molotlegi Street, Garankuwa, Pretoria 0208, South Africa.
South African Vaccination and Immunisation Centre, Sefako Makgatho Health Sciences University, Molotlegi Street, Garankuwa, Pretoria 0208, South Africa.

Amos Massele (A)

Department of Clinical Pharmacology and Therapeutics, Hurbert Kairuki Memorial University, 70 Chwaku Road Mikocheni, Dar Es Salaam P.O. Box 65300, Tanzania.

Dan Kibuule (D)

Department of Pharmacology & Therapeutics, Busitema University, Mbale P.O. Box 236, Uganda.

Aubrey C Kalungia (AC)

Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka P.O. Box 50110, Zambia.

Moyad Shahwan (M)

Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates.
Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman 346, United Arab Emirates.

Hellen Nabayiga (H)

Management Science Department, Strathclyde Business School, University of Strathclyde, 199 Cathedral Street, Glasgow G4 0QU, UK.

Giuseppe Pichierri (G)

Microbiology Department, Torbay and South Devon Foundation Trust, Lowes Bridge Torbay Hospital, Torquay TQ2 7AA, UK.

Catrin E Moore (CE)

Centre for Neonatal and Paediatric Infection, St. George's University of London, London SW17 0RE, UK.

Classifications MeSH